HDAC inhibitors (HDACi) have garnered attention owing to their inhibitory impact on essential tumor cell functions such as migration, invasion, and metastasis, consequently becoming a seminal area of investigation.[5] Increasingly, evidence suggests that HDACi not only exhibits standalone efficacy but also demonstrates a capacity to augment the effectiveness of various other treatment modalities. Here, HDAC9 is linked to neoplasm.